Virax Biolabs Group Limited (VRAX) Earnings Dates & History
NASDAQ·Healthcare·Biotechnology
$0.79
-33.45%
Mkt Cap $1.61M
EPS — Estimate vs Actual
Quarterly History
| Q4 2025 Dec 2, 2025 | — | $1.61K | — | — | -$0.49 | — |
| Q4 2024 Nov 19, 2024 | $3.00M | $4.95K | -99.83% | — | -$0.89 | — |
| Q3 2024 Aug 20, 2024 | $1.00M | $79.92K | -92.01% | — | -$1.71 | — |
| Q3 2023 Sep 30, 2023 | $400.00K | $76.50K | -80.88% | — | -$1.64 | — |
| Q3 2023 Sep 27, 2023 | $200.00K | $2.80K | -98.60% | — | -$2.58 | — |
| Q3 2022 Sep 30, 2022 | — | $5.76K | — | — | -$1.24 | — |
| Q3 2022 Aug 12, 2022 | — | -$92.86K | — | — | -$1.02 | — |
| Q3 2021 Sep 30, 2021 | — | — | — | — | -$0.49 | — |
| Q1 2021 Mar 31, 2021 | — | $109.82K | — | — | -$0.27 | — |
| Q3 2020 Sep 30, 2020 | — | $14.00K | — | — | -$0.30 | — |
| Q1 2020 Mar 31, 2020 | — | $24.97K | — | — | -$0.02 | — |